| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/20/2001 | WO2001096523A2 Polynucleotides related to colon cancer |
| 12/20/2001 | WO2001096393A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/20/2001 | WO2001096390A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096377A2 Vaccine for congenital tremors in pigs |
| 12/20/2001 | WO2001096376A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | WO2001096359A1 Compositions, methods, and kits relating to resistin-like molecules |
| 12/20/2001 | WO2001096354A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues |
| 12/20/2001 | WO2001096351A1 Inhibiting denaturation of nucleic acid duplexes |
| 12/20/2001 | WO2001096350A2 Haplotypes of the grm3 gene |
| 12/20/2001 | WO2001096025A2 Systems and methods for cell subpopulation analysis |
| 12/20/2001 | WO2001096023A2 Dielectrically-engineered microparticles |
| 12/20/2001 | WO2001095860A2 Probes for chondrogenesis |
| 12/20/2001 | WO2001095711A2 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |
| 12/20/2001 | WO2001076620A3 Use of vegf and homologues to treat neuron disorders |
| 12/20/2001 | WO2001062953A3 Electrochemical method for detecting nucleic acids |
| 12/20/2001 | WO2001062933A3 Muteins of interleukin-13 (il-13) |
| 12/20/2001 | WO2001062206A3 N-cadherin modulated migration, invasion, and metastasis |
| 12/20/2001 | WO2001060988A3 Biotechnologically interesting proteins from cat sharks |
| 12/20/2001 | WO2001059128A3 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 12/20/2001 | WO2001059100A3 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 12/20/2001 | WO2001057274A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart |
| 12/20/2001 | WO2001055367A8 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001055303A3 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001054474A8 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001053518A3 Method of assessing the viability of a cell |
| 12/20/2001 | WO2001053509A3 Biocidal molecules, macromolecular targets and methods of production and use |
| 12/20/2001 | WO2001051919A3 High-throughput formation, identification, and analysis of diverse solid-forms |
| 12/20/2001 | WO2001051601A3 Methods for the storage and synthesis of nucleic acids |
| 12/20/2001 | WO2001051006A3 Cardiac-cell specific enhancer elements and uses thereof |
| 12/20/2001 | WO2001046456A3 Biological sensor |
| 12/20/2001 | WO2001044505A3 Methods and kits for discovery of rna-binding antimicrobials |
| 12/20/2001 | WO2001044295A3 Agonists and antagonists of the receptor gpr19 and their use in appetite control |
| 12/20/2001 | WO2001044292A3 Wasp (wiskott-aldrich syndrome protein) family protein fragments, and use thereof |
| 12/20/2001 | WO2001040796A3 Glycoarrays on the surface of biochips |
| 12/20/2001 | WO2001038585A3 Polymer arrays and methods of using labeled probe molecules to identify and quantify target molecule expression |
| 12/20/2001 | WO2001038568A3 Automated method for identifying related biomolecular sequences |
| 12/20/2001 | WO2001031055A3 Method and kit for the screening and/or the quantification of multiple homologous nucleic acid sequences on arrays |
| 12/20/2001 | WO2001031016A3 Processed human chemokines phc-1 and phc-2 |
| 12/20/2001 | WO2001029207A8 Antiuracil monoclonal antibody |
| 12/20/2001 | WO2001027242A3 Methods for identifying inhibitors of methionine aminopeptidases |
| 12/20/2001 | WO2001025457A3 Gmp synthetase derived from plants |
| 12/20/2001 | WO2001007652A3 Detection of human hepatitis b virus surface antigen mutants by specific amplification and its application on gene chip |
| 12/20/2001 | WO2000071080A9 Interaction of the cyclic-amp-specific phosphodiesterase pde4d5 with rack1 |
| 12/20/2001 | WO2000067775A9 Fibroblast growth factor 15 |
| 12/20/2001 | WO2000066780A3 Adeno-associated virus-delivered ribozyme compositions and methods of use |
| 12/20/2001 | WO2000061806A3 GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS |
| 12/20/2001 | WO2000060076A3 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 12/20/2001 | WO2000058518A3 Genetic marker test for lupus |
| 12/20/2001 | WO2000058358A9 49 human secreted proteins |
| 12/20/2001 | WO2000024765A8 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/20/2001 | WO2000017103A9 Inventory control |
| 12/20/2001 | WO2000008133A9 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
| 12/20/2001 | WO1999028506A3 Cancer susceptibility mutations of brca2 |
| 12/20/2001 | US20010053958 Methods for assessing genetic and phenotypic markers by simultaneous multicolor visualization of chromogenic dyes using brightfield microscopy and spectral imaging |
| 12/20/2001 | US20010053849 Analysis of polymorphism |
| 12/20/2001 | US20010053844 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/20/2001 | US20010053541 Accumulation of preferential nucleotide sequences; provide single stranded nucleotide sequences, generate ribonucleic acids, recover ribonucleic acids |
| 12/20/2001 | US20010053540 Forming biocompatible label; provide nucleotide sequences, denature, attach compound which prevents crystalization, monitor denatured nucleotide sequences |
| 12/20/2001 | US20010053536 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
| 12/20/2001 | US20010053534 Early diagnosis of cancerous and precancerous conditions by leakage of signature peptides and carbohydrates into the bloodstream |
| 12/20/2001 | US20010053529 Apparatus for immunological detection of preferential antigen, antibody or hapten |
| 12/20/2001 | US20010053528 Immobilization on solid support |
| 12/20/2001 | US20010053527 Arrays with mask layers and methods of manufacturing same |
| 12/20/2001 | US20010053526 Generation of nucleotide sequence libraries; provide nucleotide sequences and primers, amplify and recover nucleotide sequences |
| 12/20/2001 | US20010053524 Cell libraries indexed to nucleic acid microarrays |
| 12/20/2001 | US20010053523 Method for identification of biologically active peptides and nucleic acids |
| 12/20/2001 | US20010053522 Nucleic acids detection |
| 12/20/2001 | US20010053519 Nucleotide sequences for use as tool in genetic engineering |
| 12/20/2001 | US20010053518 Simple and accurate detetion of ribonucleic acids in a sample; generate mixture, detect signal from sample |
| 12/20/2001 | US20010053517 Sequencing ncleotide sequences of tissue samples; otain tissue, homogenize, extract nucleotide sequence, sequence |
| 12/20/2001 | US20010053516 Computer method and system for correlating data |
| 12/20/2001 | US20010053497 Arrays with mask layers and methods of manufacturing same |
| 12/20/2001 | US20010052976 Scanning optical detection system |
| 12/20/2001 | US20010052580 Method and apparatus for exposing stimulable phosphor sheet |
| 12/20/2001 | US20010052472 Reaction layer formed on the insulating substrate which contains an oxidoreductase and an electron acceptor, wherein the electron acceptor is ferricinium ion derived from ferrocene electrolyte. |
| 12/20/2001 | US20010052470 Electrochemical cell |
| 12/20/2001 | DE10053393A1 Verfahren zur Immobilisierung von Nukleinsäuren A process for the immobilization of nucleic acids |
| 12/20/2001 | DE10028837A1 Detecting infection by influenza A or B virus, comprises rapid analysis of a saliva sample, with detection of nucleic acid or nucleoprotein |
| 12/20/2001 | DE10027607A1 Applying micro- or nanoparticles of magnetically interacting material, loaded with e.g. nucleic acids to a magnetic carrier for analysis, comprises applying an external magnetic field to accelerate particles into recesses |
| 12/20/2001 | DE10027383A1 Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz Nucleic acid molecule comprising a sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide nucleic acid sequence |
| 12/20/2001 | DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase |
| 12/20/2001 | DE10019058A1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
| 12/20/2001 | CA2804117A1 Method for modifying plant morphology, biochemistry and physiology |
| 12/20/2001 | CA2413194A1 Systems and methods for cell subpopulation analysis |
| 12/20/2001 | CA2413020A1 Detection of nucleic acids by type-specific hybrid capture method |
| 12/20/2001 | CA2413013A1 Novel motor proteins and methods for their use |
| 12/20/2001 | CA2412998A1 Methods of dissociating nongenotropic from genotropic activity of steroid receptors |
| 12/20/2001 | CA2412993A1 Method of identifying and quantifying specific fungi and bacteria |
| 12/20/2001 | CA2412966A1 Compositions containing a urea derivative dye for detecting an analyte |
| 12/20/2001 | CA2412769A1 Toxicity typing using mesenchymal stem cells |
| 12/20/2001 | CA2412665A1 Scramblase 2 |
| 12/20/2001 | CA2412664A1 Regulatable, catalytically active nucleic acids |
| 12/20/2001 | CA2412663A1 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
| 12/20/2001 | CA2412579A1 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 12/20/2001 | CA2412521A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki) |
| 12/20/2001 | CA2412317A1 A method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality |
| 12/20/2001 | CA2412257A1 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | CA2412223A1 Compositions and methods for the therapy and diagnosis of colon cancer |